These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16472097)

  • 1. Topical DermaVir vaccine targeting dendritic cells.
    Lisziewicz J; Kelly L; Lori F
    Curr Drug Deliv; 2006 Jan; 3(1):83-8. PubMed ID: 16472097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DermaVir, a novel HIV immunisation technology.
    Lori F; Trocio J; Bakare N; Kelly LM; Lisziewicz J
    Vaccine; 2005 Mar; 23(17-18):2030-4. PubMed ID: 15755566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DermaVir: a novel topical vaccine for HIV/AIDS.
    Lisziewicz J; Trocio J; Whitman L; Varga G; Xu J; Bakare N; Erbacher P; Fox C; Woodward R; Markham P; Arya S; Behr JP; Lori F
    J Invest Dermatol; 2005 Jan; 124(1):160-9. PubMed ID: 15654970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.
    Lisziewicz J; Bakare N; Calarota SA; Bánhegyi D; Szlávik J; Ujhelyi E; Tőke ER; Molnár L; Lisziewicz Z; Autran B; Lori F
    PLoS One; 2012; 7(5):e35416. PubMed ID: 22590502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanochemistry-based immunotherapy for HIV-1.
    Lori F; Calarota SA; Lisziewicz J
    Curr Med Chem; 2007; 14(18):1911-9. PubMed ID: 17691933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.
    Lori F
    Expert Rev Vaccines; 2011 Oct; 10(10):1371-84. PubMed ID: 21988301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of viral rebound through therapeutic immunization with DermaVir.
    Lisziewicz J; Trocio J; Xu J; Whitman L; Ryder A; Bakare N; Lewis MG; Wagner W; Pistorio A; Arya S; Lori F
    AIDS; 2005 Jan; 19(1):35-43. PubMed ID: 15627031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
    Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K
    Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.
    Yao WR; Li D; Yu L; Wang FJ; Xing H; Yang GB
    Immunol Res; 2017 Aug; 65(4):869-879. PubMed ID: 28478499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
    Cristillo AD; Lisziewicz J; He L; Lori F; Galmin L; Trocio JN; Unangst T; Whitman L; Hudacik L; Bakare N; Whitney S; Restrepo S; Suschak J; Ferrari MG; Chung HK; Kalyanaraman VS; Markham P; Pal R
    Virology; 2007 Sep; 366(1):197-211. PubMed ID: 17499328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
    Calarota SA; Weiner DB; Lori F; Lisziewicz J
    Vaccine; 2007 Apr; 25(16):3070-4. PubMed ID: 17292518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic dendritic-cell vaccine for simian AIDS.
    Lu W; Wu X; Lu Y; Guo W; Andrieu JM
    Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in dendritic cell migration and activation during SIV infection suggest a role in initial viral spread and eventual immunosuppression.
    Barratt-Boyes SM; Zimmer MI; Harshyne L
    J Med Primatol; 2002 Aug; 31(4-5):186-93. PubMed ID: 12390541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.
    LaFranco-Scheuch L; Abel K; Makori N; Rothaeusler K; Miller CJ
    J Virol; 2004 Jun; 78(12):6399-408. PubMed ID: 15163733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological approaches for HIV therapy.
    Lori F; Kelly LM; Lisziewicz J
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):171-8. PubMed ID: 12769793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.
    Nehete PN; Nehete BP; Manuri P; Hill L; Palmer JL; Sastry KJ
    Vaccine; 2005 Mar; 23(17-18):2154-9. PubMed ID: 15755586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.
    Cobb A; Roberts LK; Palucka AK; Mead H; Montes M; Ranganathan R; Burkeholder S; Finholt JP; Blankenship D; King B; Sloan L; Harrod AC; Lévy Y; Banchereau J
    J Immunol Methods; 2011 Feb; 365(1-2):27-37. PubMed ID: 21093448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.